Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000729270 | SCV000856917 | uncertain significance | not provided | 2017-09-12 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002507289 | SCV002806957 | uncertain significance | Hypercholanemia, familial, 2 | 2022-02-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004026970 | SCV003873565 | uncertain significance | not specified | 2023-03-06 | criteria provided, single submitter | clinical testing | The c.559G>C (p.V187L) alteration is located in exon 2 (coding exon 2) of the SLC10A1 gene. This alteration results from a G to C substitution at nucleotide position 559, causing the valine (V) at amino acid position 187 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |